Finland· FI-REL-REL1479
Antistin-Privin
A naphazolin, kombinationen product containing antazoline sulfate + naphazoline nitrate, registered in Finland by Novartis Healthcare A/S. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Naphazolin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC S01GA51 (naphazolin, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Naphazolin, kombinationen · ATC S01GA51
6 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Antazoline sulfate + Naphazoline nitrate
- Manufacturer
- Novartis Healthcare A/S
- Country
- Finland (FI)
- ATC code
- S01GA51
- ATC class
- Naphazolin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naphazolin, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALERGOFTAL 0,25 mg/ml+ 5 mg/ml COLIRIO EN SOLUCIONReva Health Europe S.L.
- CanadaREFRESH EYE ALLERGY RELIEFABBVIE CORPORATION
- CzechiaSANORIN COMBIFARMAK INTERNATIONAL Sp.z.o.o., Varšava
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Sanorin Combi
- Spain · Alergoftal, Optialerg
- Portugal · Alergiftalmina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1711d591-af33-4843-a4f6-feccf00123d1 GET /v1/drugs/1711d591-af33-4843-a4f6-feccf00123d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "nafatsoliini, yhdistelmävalmisteet",
"ma_number": "8291",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL1479",
"authorised_at": "1982-02-10"
}See everything about naphazolin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.